Health-care companies rallied after another breakthrough on Covid-19 for a pharma giant.
Pfizer said a preliminary look at study results found that its experimental pill, Paxlovid, was highly effective at preventing people at high risk of severe Covid-19 from needing hospitalization or dying, the latest encouraging performance for an early virus treatment.
The federal government and Emergent BioSolutions terminated a pandemic-preparedness contract after the contract drug manufacturer experienced problems manufacturing Covid-19 vaccines.
Canopy Growth shares fell to their lowest levels since early 2020, after the cannabis company said it expects slower-than-expected revenue growth in the second half of fiscal 2022.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
11-05-21 1659ET
